Boehringer Ingelheim opens new China R&D center in Shanghai
english.shanghai.gov.cn|
October 20, 2026
German biopharma giant Boehringer Ingelheim has inaugurated a new China R&D center in Shanghai to expand its early clinical development capabilities. Ioannis Sapountzis, president and CEO of Boehringer Ingelheim Greater China, said China's regulatory environment has been supportive of innovation.
In Focus
FAQs
- Do I need a physical marriage certificate when applying for a residence permit for private affairs?
- Do I need to declare my ADHD medication to customs during an airside transit at Shanghai Pudong Airport?
- Is Wusongkou International Cruise Terminal an eligible port under the 240-hr visa-free transit policy?
- What are the customs and quarantine requirements for pets entering or leaving China via Shanghai Pudong airport?